33 reports

  • 15.14.1 The NGS-based RNA-seq Market By Agreements
  • NGS BASED RNA SEQ SEGMENTATION, BY REGION

TABLE ##. ##.

  • RNA
  • World
  • Forecast
  • Market Size
  • Illumina, Inc.

About this market The rise in several clinical trials in developing countries is one of the key factors anticipated to trigger market growth during the forecast period.

  • Genomics Proteomics And Enabling Technology
  • RNA
  • World
  • Forecast

##.

  • RNA
  • World
  • Demand
  • Forecast
  • Market Size

RNA Technologies Enabling Drug Discovery and Development ##. ## Executive Summary ##. ## Research Scope: RNA Therapies Redefining the Healthcare Landscape ##. ## Analysis Framework: Frost & Sullivan’s Core Value ##. ## Research Methodology: Five Steps Towards Success ##. ## Key Findings ##. ##

  • Genomics Proteomics And Enabling Technology
  • Pharmaceutical
  • RNA
  • Therapy

RNA Therapies in Oncology: Analytical Tool RNA therapies, such as miRNA, RNAi & amp; siRNA, is an emerging class of biopharmaceutical that has immense potential in cancer medicine.

  • Genomics Proteomics And Enabling Technology
  • Oncology
  • RNA
  • Therapy
  • World

Global DNA and RNA Isolation Kits Figure ##.

  • RNA
  • APAC
  • North America
  • South America
  • World

RNA Sequencing: Technologies and Global Markets CHAPTER ## INTRODUCTION ## STUDY GOALS AND OBJECTIVES ## REASONS FOR DOING THE STUDY ## INTENDED AUDIENCE ## SCOPE AND FORMAT ## METHODOLOGY AND INFORMATION SOURCES ## ANALYST' S CREDENTIALS ## RELATED BCC RESEARCH REPORTS ## BCC RESEARCH

  • Biotechnology
  • Genomics
  • Genomics Proteomics And Enabling Technology
  • RNA
  • World
  • Other prominent vendors
  • Market size and forecast 2016-2021

It offers product such as bioZOLTM-G RNA Isolation Reagent and All-in-One (RNA/ DNA/ Protein) Purification Kit.

  • RNA
  • Agilent Technologies, Inc.
  • F. Hoffmann-La Roche Ltd.
  • GE Healthcare Limited
  • Thermo Fisher Scientific, Inc.
  • RNA SEQUENCING
  • SMALL RNA SEQUENCING WORKFLOW

(U. S. ) for the commercialization of its RealSeq-AC library preparation technology which offers small RNA sequencing and micro-RNAs sequencing. ##. ##. ##. ##. ## L i b r a r y p r e p a r a t i o n a n d t a r g e t e n r i c h m e n t ##. ##. ##.

  • Biotech Diagnostics
  • RNA
  • North America
  • World
  • Illumina, Inc.
  • RNA INTERFERENCE (RNAI) MARKET: REVENUE IN USD
  • RNA INTERFERENCE (RNAI) MARKET: REVENUE IN USD MILLION, CANADA, 2016-2024

One of them was Sirna-##, which is a chemically-modified short interfering RNA (siRNA) targeting vascular endothelial growth factor receptor-## (VEGFR-##).

  • RNA
  • United States
  • World
  • Forecast
  • RNAi company

Indicated by CTC cfDNA-RNA 2015 participants (Study ##) Table ##. ##.

  • Biotechnology
  • Diagnostics
  • Medical Biotechnology
  • Molecular Diagnostics
  • RNA

RNA probes, detection technologies, biochips, genosensors, microarrays, labs-on-the-chip, and other.

  • DNA
  • RNA
  • Company Operations
  • Demand
  • Market Size
  • LOW REPRESENTATION OF MIRNA AMONG RNA SPECIES
  • THREE: MIRNA PROFILING AND FUNCTIONAL ANALYSIS TECHNOLOGIES 73

THE QSTAR SYSTEM REQUIRES ## ΜG OF TOTAL RNA INPUT.

  • RNA
  • Illumina, Inc.
  • Mirna Therapeutics, Inc.
  • QIAGEN N.V.
  • Sigma-Aldrich
  • RNA Disruption Assay - Breast Cancer - Product Description
  • RNA Disruption Assay - Breast Cancer - Product Status

Rna Diagnostics is one of three businesses selected to participate in this pilot program.

  • Breast Cancer
  • Diagnostics
  • RNA
  • Canada
  • Company
  • RNA Aptamer
  • 6.3 RNA-BASED APTAMERS

B U S I N E S S O V E R V I E W ## ##. ##. ## Established in 2008 and headquartered in York, U. K., Aptamer Solutions Ltd. develops and manufactures DNA and RNA aptamers.

  • RNA
  • Aptamer Sciences Inc.
  • Base Pair Biotechnologies, Inc.
  • SomaLogic, Inc.
  • Vivonics, Inc.
  • Absolutely Total RNA Purification Kits Absolutely RNA 96 Microprep Kit
  • 8.3 TOTAL RNA ISOLATION AND PURIFICATION

Thus, the introduction of new technologies is expected to drive this market in the coming years. ##. ##. ##. ## ##. ##. ## RESTRAINTS ##. ##. ##. ## H i g h c o s t o f a u t o m a t e d i n s t r u m e n t s Nucleic acid isolation and purification using kits and automat

  • RNA
  • North America
  • United States
  • Forecast
  • QIAGEN N.V.
  • WAFERGEN BIOSYSTEMS ENTERS INTO LICENSING AGREEMENT WITH RUTGERS UNIVERSITY FOR RNA QUALITY CONTROL TECHNOLOGY

Its Apollo ## system processes DNA and RNA from clinical samples to NGSready libraries.

  • Healthcare
  • RNA
  • United States
  • M&A
  • WaferGen Bio-systems, Inc.
  • MAY 15, 2018: EXOSOME DIAGNOSTICS PRESENTS BREAKTHROUGH DATA HIGHLIGHTING TUMOR DERIVED RNA IN BIOFLUIDS AT THE INTERNATIONAL SOCIETY FOR EXTRACELLULAR VESICLES IN SPAIN
  • APR 17, 2018: EXOSOME DIAGNOSTICS OBVIATES TISSUE BIOPSIES

This capability (Exosome' s patented EDDE technology) allows us to see the actual RNA signatures from the tissue from as little as ## ml of plasma, obviating the need for tissue to analyze tumor specific RNA changes.

  • Diagnostics
  • Medical Device
  • RNA
  • United States
  • Exosome Diagnostics, Inc.
  • EOSCAPE-HCV RNA - PRODUCT DESCRIPTION
  • EOSCAPE-HCV RNA - PRODUCT STATUS

Wave ## provides EOSCAPE-HIV, an in vitro nucleic acid assay, which enables the detection and quantitation of human immunodeficiency virus type ## (HIV-##) RNA.

  • Clinical Trial
  • Hepatitis
  • Hepatitis Testing
  • RNA
  • Merck & Co., Inc.
  • EOSCAPE-HCV RNA
  • EOSCAPE-HCV RNA Product Overview

Wave ## provides EOSCAPE-HIV, an in vitro nucleic acid assay, which enables the detection and quantitation of human immunodeficiency virus type ## (HIV-##) RNA.

  • Diagnostics
  • Hepatitis
  • Infectious Disease
  • RNA
  • Tuberculosis
  • DEC 19, 2017: SOMAGENICS RECEIVES AWARD OR ALLOWANCE OF FOUR PATENTS COVERING ITS SMALL RNA ANALYSIS AND THERAPEUTICS
  • OCT 10, 2017: SOMAGENICS AWARDED NIH FUNDING TO DEVELOP NGS SINGLE-CELL ANALYSIS OF SMALL RNAS

One grant supports further development of miR-Direct, ™ a novel RT-qPCR based assay for quantifying circulating extracellular miRNAs by directly assaying plasma or serum samples. miR-Direct™ eliminates the need for total RNA isolation, the most problematic and bias-prone step in cur

  • Molecular Diagnostics
  • RNA
  • United States
  • Company Operations
  • SomaGenics, Inc.
  • JUN 27, 2017: RANA THERAPEUTICS RELAUNCHES AS TRANSLATE BIO TO ADVANCE RNA THERAPEUTICS
  • RANA THERAPEUTICS ENTERS INTO LICENSING AGREEMENT WITH SANTARIS PHARMA TO DEVELOP RNA-TARGETED MEDICINES

SR One Ltd.

  • Pharmaceutical
  • RNA
  • Therapy
  • United States
  • Company
  • 2.2.3 RNA
  • 2.3.4 CIRCULATING RNA IN PREGNANCY

As already described it is known that circulating DNA and RNA are present in the plasma and serum of health individuals at a concentration of ##. ## - ## ng mL-## and (##. ##ng mL-##) respectively.

  • RNA
  • Ariosa Diagnostics, Inc.
  • Illumina, Inc.
  • Natera, Inc.
  • Sequenom, Inc.
  • RANA THERAPEUTICS ENTERS INTO LICENSING AGREEMENT WITH SANTARIS PHARMA TO DEVELOP RNA-TARGETED MEDICINES
  • JUN 27, 2017: RANA THERAPEUTICS RELAUNCHES AS TRANSLATE BIO TO ADVANCE RNA THERAPEUTICS

SR One Ltd.

  • Pharmaceutical
  • RNA
  • Therapy
  • United States
  • Company
  • Sep 20, 2018: Decoding the structure of an RNA-based CRISPR system
  • Mar 14, 2018: CRISPR genetic editing takes another big step forward, targeting RNA

" This paper provides a molecular blueprint for RNA-targeted genetic engineering, says Salk Assistant Professor Dmitry Lyumkis, a structural biologist and one of the corresponding authors of the study.

  • Cancer
  • Healthcare
  • Pharmaceutical
  • RNA
  • United States
  • 2.2.3 RNA
  • 2.2.3.4 RNA INTERFERENCE (RNAI)

The majority of RNA molecules are tRNAs and rRNAs. mRNA accounts for only ##-##% of the total ##. ##. ## RNA © 2014 Veracity Health Reports.

  • RNA
  • World
  • Affymetrix, Inc.
  • QIAGEN N.V.
  • Roche Group
  • NEW ENGLAND BIOLABS ENTERS INTO LICENSING AGREEMENT WITH GENOMIC HEALTH FOR RIBOSOMAL RNA DEPLETION TECHNOLOGY

We' ve even pushed the input as low as ## ng for very high quality total RNA.

  • Medical Device
  • RNA
  • United States
  • Deals & Alliance
  • New England Biolabs, Inc.
  • JUN 15, 2017: PROQR R&D DAY HIGHLIGHTS PROGRESS ON PIPELINE AND INTRODUCES AXIOMER, A NOVEL PROPRIETARY RNA TECHNOLOGY
  • MAY 23, 2018: PROQR APPOINTS YI-TAO YU TO ITS SCIENTIFIC ADVISORY BOARD

ONE OF THE MOST INTERESTING IS AN RNA PROCESS USED IN NATURE CALLED A TO I EDITING OR ADAR.

  • Pharmaceutical
  • RNA
  • Therapy
  • United States
  • ProQR Therapeutics N.V.
  • SMALL MOLECULE TO TARGET CUG RNA FOR MYOTONIC DYSTROPHY 1 - DRUG PROFILE
  • SMALL MOLECULE TO TARGET RNA FOR MYOTONIC DYSTROPHY - DRUG PROFILE

This platform targets two types of RNA, namely, coding RNA and non-coding RNA.

  • RNA
  • United States
  • World
  • Company Operations
  • Product Initiative

It also provides DNA and RNA extraction mini kits, molecular reagents, gel PCR kits and ISO thermal cycling based kits.

  • Biomarker
  • Clinical Trial
  • Immunodiagnostics
  • RNA
  • Abbott